SH
Shrikant Hambirrao Rane
About Shrikant Hambirrao Rane
Data last updated:
Shrikant Hambirrao Rane is a Director at Croient Pharma Private Limited (since 2012) and Director at Ransaw Remedies Private Limited (since 2020). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹19.53 Cr; the largest is Croient Pharma Private Limited at ₹19.13 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Croient Pharma Private Limited U24233MH2012PTC226900 | Director | 14 Feb 2012 | 2012 | ₹19.13 Cr (FY 2024) | Active |
 Ransaw Remedies Private Limited U24239MH2020PTC351993 | Director | 16 Dec 2020 | 2020 | ₹40.2 Lakh (FY 2024) | Active |
Board colleagues of Shrikant Hambirrao Rane
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dinesh Balkrishna Sawant | 05170597 | Croient Pharma Private Limited , Ransaw Remedies Private Limited | Director |
| Pawankumar Babasaheb Ankalkope | 05165919 | Croient Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shrikant Hambirrao Rane
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shrikant Hambirrao Rane
Shrikant Hambirrao Rane currently holds 2 directorships: Croient Pharma Private Limited (Director, since 14 Feb 2012, revenue ₹19.13 Cr (FY 2024)); Ransaw Remedies Private Limited (Director, since 16 Dec 2020, revenue ₹40.2 Lakh (FY 2024)).
Shrikant Hambirrao Rane was first appointed on 14 Feb 2012 as Director at Croient Pharma Private Limited. The most recent appointment on record is 16 Dec 2020 at Ransaw Remedies Private Limited.
The 2 current companies of Shrikant Hambirrao Rane that report revenue have a combined latest revenue of ₹19.53 Cr: Croient Pharma Private Limited ₹19.13 Cr (FY 2024); Ransaw Remedies Private Limited ₹40.2 Lakh (FY 2024).
The current boards of Shrikant Hambirrao Rane's companies include Dinesh Balkrishna Sawant (Croient Pharma Private Limited), Pawankumar Babasaheb Ankalkope (Croient Pharma Private Limited).